192 related articles for article (PubMed ID: 31500625)
21. Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness.
Ruiz-Plazas X; Altuna-Coy A; Alves-Santiago M; Vila-Barja J; García-Fontgivell JF; Martínez-González S; Segarra-Tomás J; Chacón MR
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33440913
[TBL] [Abstract][Full Text] [Related]
22. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
23. Sarcopenia is associated with hypomethylation of TWEAK and increased plasma levels of TWEAK and its downstream inflammatory factor TNF-α in older adults: A case-control study.
Xuekelati S; Maimaitiwusiman Z; Bai X; Xiang H; Li Y; Wang H
Exp Gerontol; 2024 Apr; 188():112390. PubMed ID: 38437928
[TBL] [Abstract][Full Text] [Related]
24. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers.
Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y
Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970
[TBL] [Abstract][Full Text] [Related]
25. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
[TBL] [Abstract][Full Text] [Related]
26. Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4-10 ng/mL.
Zhou Y; Li Y; Li X; Jiang M
Biomed Res Int; 2017; 2017():2512536. PubMed ID: 28293631
[TBL] [Abstract][Full Text] [Related]
27. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
29. LncRNA Snhg3 contributes to dysfunction of cerebral microvascular cells in intracerebral hemorrhage rats by activating the TWEAK/Fn14/STAT3 pathway.
Zhang J; Dong B; Hao J; Yi S; Cai W; Luo Z
Life Sci; 2019 Nov; 237():116929. PubMed ID: 31610210
[TBL] [Abstract][Full Text] [Related]
30. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
[TBL] [Abstract][Full Text] [Related]
31. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.
Avilés-Jurado FX; Terra X; Gómez D; Flores JC; Raventós A; Maymó-Masip E; León X; Serrano-Gonzalvo V; Vendrell J; Figuerola E; Chacón MR
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1733-41. PubMed ID: 24858806
[TBL] [Abstract][Full Text] [Related]
32. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
Martínez-Aranda A; Hernández V; Guney E; Muixí L; Foj R; Baixeras N; Cuadras D; Moreno V; Urruticoechea A; Gil M; Oliva B; Moreno F; González-Suarez E; Vidal N; Andreu X; Seguí MA; Ballester R; Castella E; Sierra A
Oncotarget; 2015 Dec; 6(42):44254-73. PubMed ID: 26497551
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
[TBL] [Abstract][Full Text] [Related]
34. Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
Güner G; Aßfalg M; Zhao K; Dreyer T; Lahiri S; Lo Y; Slivinschi BI; Imhof A; Jocher G; Strohm L; Behrends C; Langosch D; Bronger H; Nimsky C; Bartsch JW; Riddell SR; Steiner H; Lichtenthaler SF
EMBO Mol Med; 2022 Oct; 14(10):e16084. PubMed ID: 36069059
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.
Asil M; Dertli R
Medicine (Baltimore); 2016 Sep; 95(37):e4763. PubMed ID: 27631226
[TBL] [Abstract][Full Text] [Related]
36. A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis.
Rodríguez-Muguruza S; Altuna-Coy A; Castro-Oreiro S; Poveda-Elices MJ; Fontova-Garrofé R; Chacón MR
Front Immunol; 2021; 12():790880. PubMed ID: 34868079
[TBL] [Abstract][Full Text] [Related]
37. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
De Nunzio C; Lombardo R; Albisinni S; Gacci M; Tubaro A
Int Braz J Urol; 2013; 39(6):793-9. PubMed ID: 24456771
[TBL] [Abstract][Full Text] [Related]
39. A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples.
Guo J; Yang J; Zhang X; Feng X; Zhang H; Chen L; Johnson H; Persson JL; Xiao K
Anticancer Res; 2018 Mar; 38(3):1471-1477. PubMed ID: 29491074
[TBL] [Abstract][Full Text] [Related]
40. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
